Larimar Therapeutics Inc (LRMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -74,286 | -36,478 | -14,027 | -13,880 | -13,157 |
| Depreciation Amortization | 1,313 | 47 | 12 | 11 | 4 |
| Accounts payable and accrued liabilities | 4,914 | 815 | 237 | 727 | -43 |
| Other Working Capital | 6,729 | 3,154 | -1,634 | 62 | 801 |
| Other Operating Activity | 1,776 | 4,221 | 408 | -509 | 121 |
| Operating Cash Flow | $-59,554 | $-28,241 | $-15,004 | $-13,589 | $-12,274 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -91,504 | -57,200 | N/A | N/A | N/A |
| PPE Investments | -595 | -58 | -17 | -2 | -33 |
| Other Investing Activity | -19 | -57 | 0 | 0 | -12 |
| Investing Cash Flow | $-92,118 | $-57,315 | $-17 | $-2 | $-45 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 7,386 | N/A | 5,989 | N/A |
| Common Stock Issued | 131,018 | 102,675 | N/A | 13 | N/A |
| Common Stock Repurchased | -473 | -2,312 | -196 | N/A | N/A |
| Other Financing Activity | -1,381 | 393 | 40,799 | 16,057 | 10,069 |
| Financing Cash Flow | $129,164 | $108,142 | $40,603 | $22,059 | $10,069 |
| Beginning Cash Position | 58,103 | 35,517 | 9,935 | 1,467 | 3,717 |
| End Cash Position | 35,595 | 58,103 | 35,517 | 9,935 | 1,467 |
| Net Cash Flow | $-22,508 | $22,586 | $25,582 | $8,468 | $-2,250 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,554 | -28,241 | -15,004 | -13,589 | -12,274 |
| Capital Expenditure | -595 | -58 | -17 | -2 | -35 |
| Free Cash Flow | -60,149 | -28,299 | -15,021 | -13,591 | -12,309 |